FDA advisers discuss pediatric cancer meds

12/4/2012 | Bloomberg

A panel of FDA advisers is meeting to discuss testing four drugs with potential to treat childhood cancers. Relatively few children are affected by cancer, making robust clinical trial design difficult. The FDA requires drugmakers to study their products in children if that population is prone to the target disease, and new legislation taking effect next month will require those studies even earlier.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA